FI970489L - Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät doksepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon - Google Patents

Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät doksepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon Download PDF

Info

Publication number
FI970489L
FI970489L FI970489A FI970489A FI970489L FI 970489 L FI970489 L FI 970489L FI 970489 A FI970489 A FI 970489A FI 970489 A FI970489 A FI 970489A FI 970489 L FI970489 L FI 970489L
Authority
FI
Finland
Prior art keywords
treatment
compositions containing
eye diseases
ophthalmic compositions
topical ophthalmic
Prior art date
Application number
FI970489A
Other languages
English (en)
Swedish (sv)
Other versions
FI970489A7 (fi
FI970489A0 (fi
Inventor
John Michael Yanni
Stella M Robertson
Eiji Hayakawa
Masashi Nakakura
Original Assignee
Alcon Lab Inc
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23864859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI970489(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Lab Inc, Kyowa Hakko Kogyo Kk filed Critical Alcon Lab Inc
Publication of FI970489A7 publication Critical patent/FI970489A7/fi
Publication of FI970489A0 publication Critical patent/FI970489A0/fi
Publication of FI970489L publication Critical patent/FI970489L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI970489A 1995-06-06 1996-05-03 Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät doksepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon FI970489L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/469,729 US5641805A (en) 1995-06-06 1995-06-06 Topical ophthalmic formulations for treating allergic eye diseases
PCT/US1996/006289 WO1996039147A2 (en) 1995-06-06 1996-05-03 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases

Publications (3)

Publication Number Publication Date
FI970489A7 FI970489A7 (fi) 1997-02-05
FI970489A0 FI970489A0 (fi) 1997-02-05
FI970489L true FI970489L (fi) 1997-02-05

Family

ID=23864859

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970489A FI970489L (fi) 1995-06-06 1996-05-03 Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät doksepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon

Country Status (20)

Country Link
US (1) US5641805A (fi)
EP (1) EP0799044B1 (fi)
JP (1) JP3068858B2 (fi)
KR (1) KR100202155B1 (fi)
CN (1) CN1082367C (fi)
AT (1) ATE220906T1 (fi)
AU (1) AU698854B2 (fi)
CA (1) CA2195094C (fi)
DE (2) DE69622527T2 (fi)
DK (1) DK0799044T3 (fi)
ES (1) ES2179198T3 (fi)
FI (1) FI970489L (fi)
LU (1) LU90969I2 (fi)
MX (1) MX9701013A (fi)
MY (1) MY116651A (fi)
NL (1) NL300101I2 (fi)
NO (1) NO311637B1 (fi)
PT (1) PT799044E (fi)
TW (1) TW438588B (fi)
WO (1) WO1996039147A2 (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859000A (en) * 1995-06-07 1999-01-12 University Of Utah Research Foundation Method for reducing mast cell mediated allergic reactions
BR9906772A (pt) * 1998-07-14 2000-09-26 Alcon Lab Inc Uso de ácido 11-(3-dimetilamino-propilideno)-6,11diidrodibenz[b,e]o xepin-2-acético para a fabricação de um medicamento para tratamento de desordens inflamatórias oftálmicas não-alérgicas e para prevenção de neovascularização ocular
US6174914B1 (en) 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
US6420399B1 (en) 1999-06-18 2002-07-16 Alcon Manufacturing, Ltd. Topical ophthalmic mast cell stabilizers for treating allergic eye disease
CA2395866C (en) 2000-01-25 2009-10-13 Alcon, Inc. Ophthalmic anti-allergy compositions suitable for use with contact lenses
AU2001253807B2 (en) 2000-05-19 2005-02-17 Alcon, Inc. Compositions containing a benzamide disulfide derivative for treating allergic diseases
JP2003534317A (ja) 2000-05-19 2003-11-18 アルコン，インコーポレイテッド アレルギー性疾患を処置するためのアニリンジスルフィド誘導体
AU2001255675B2 (en) 2000-05-19 2005-04-14 Alcon, Inc. Disulfide derivatives useful for treating allergic diseases
WO2002089615A2 (en) * 2001-05-03 2002-11-14 Novartis Ag Anti-ige antibody to treat ocular allergies
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
CA2468749A1 (en) * 2001-12-05 2003-06-19 Alcon, Inc. Use of an h1 antagonist and a safe steroid to treat rhinitis
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
MXPA06014648A (es) * 2004-06-28 2007-02-12 Alcon Inc Formulaciones topicas para tratar pacedimientos alergicos.
EP1814538B1 (en) * 2004-11-24 2009-09-23 Alcon, Inc. Method of delivering nasal spray
ES2437077T3 (es) * 2005-07-08 2014-01-08 Senju Pharmaceutical Co., Ltd. Preparado oftálmico de absorción percutánea que comprende olopatadina
PL3150209T3 (pl) 2006-03-31 2020-03-31 Vistakon Pharmaceuticals, Llc Leczenie alergii oczu
US20080139531A1 (en) * 2006-12-04 2008-06-12 Alcon Manufacturing Ltd. Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
PT2114367E (pt) 2007-02-07 2016-02-01 Novartis Ag Formulações de olopatadina para administração nasal tópica
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
MX2009010946A (es) * 2007-04-11 2009-10-29 Alcon Res Ltd Uso de un inhibidor del factor de necrosis tumoral alfa mas una antihistamina para tratar rinitis alergica y conjuntivitis alergica.
JP5307015B2 (ja) * 2007-09-06 2013-10-02 協和発酵キリン株式会社 ジベンゾ［ｂ，ｅ］オキセピン誘導体含有点眼剤
US10517839B2 (en) * 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
IT1397503B1 (it) 2009-04-21 2013-01-16 F S I Fabbrica Italiana Sint Processo per la preparazione di olopatadina
CN102470099A (zh) * 2009-07-17 2012-05-23 爱尔康研究有限公司 儿童用奥洛他定鼻腔喷雾方案
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
KR20120091037A (ko) * 2009-10-01 2012-08-17 알콘 리서치, 리미티드 올로파타딘 조성물 및 그의 용도
TW201206936A (en) 2010-07-19 2012-02-16 Alcon Res Ltd Methods and compositions for the treatment of allergy
TWI544922B (zh) * 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
CN103202833A (zh) * 2012-12-25 2013-07-17 常州市亚邦医药研究所有限公司 一种奥洛他定或其盐的药用组合物及其制备方法
CA2929074A1 (en) * 2013-10-31 2015-05-07 Nephron Pharmaceuticals Corporation Formulation of olopatadine
CN113985041A (zh) * 2021-09-29 2022-01-28 武汉钢铁有限公司 一种实验室检测设备精度控制的控制限的设定方法及装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370324A (en) * 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤

Also Published As

Publication number Publication date
AU5726196A (en) 1996-12-24
MX9701013A (es) 1997-05-31
EP0799044B1 (en) 2002-07-24
FI970489A7 (fi) 1997-02-05
JP3068858B2 (ja) 2000-07-24
US5641805A (en) 1997-06-24
FI970489A0 (fi) 1997-02-05
EP0799044A2 (en) 1997-10-08
DE10299034I2 (de) 2005-07-07
DE69622527T2 (de) 2002-12-05
NO970517L (no) 1997-04-03
DK0799044T3 (da) 2002-10-14
CN1082367C (zh) 2002-04-10
NL300101I1 (nl) 2002-12-02
CA2195094A1 (en) 1996-12-12
JPH09510235A (ja) 1997-10-14
WO1996039147A3 (en) 1997-02-20
KR100202155B1 (ko) 1999-06-15
KR970704452A (ko) 1997-09-06
DE10299034I1 (de) 2003-01-23
WO1996039147A2 (en) 1996-12-12
NL300101I2 (nl) 2003-01-06
PT799044E (pt) 2002-11-29
NO970517D0 (no) 1997-02-05
CN1161000A (zh) 1997-10-01
NO311637B1 (no) 2001-12-27
MY116651A (en) 2004-03-31
AU698854B2 (en) 1998-11-12
TW438588B (en) 2001-06-07
CA2195094C (en) 2002-02-26
ES2179198T3 (es) 2003-01-16
LU90969I2 (fr) 2002-12-02
DE69622527D1 (de) 2002-08-29
ATE220906T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
FI970489L (fi) Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät doksepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
FI963696L (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
AU6916694A (en) Novel treatments for allergic diseases
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
BR9607145A (pt) Implante de córnea para alterar propriedades de refração
FI933902A7 (fi) Substituoidut sykloheksaanijohdannaiset sairauksien hoitamiseksi
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
HK1038694A1 (zh) 治疗眼、耳、鼻病症的抗生素合成剂
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
IL125002A0 (en) Novel substituted 4-(1H-benzimidazol-2-yl) [1,4] diazepanes useful for the treatment of allergic diseases
DE69618560D1 (de) Medikament gegen ophthalmische erkrankungen
FI971584A7 (fi) Estävä ja hoitava aine tyypin I allergiatauteja varten
ATE198192T1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
FI952203L (fi) Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi
FI911533A7 (fi) Bentsoksatsiini-johdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö sairauksien hoitamiseen tai ennalta ehkäisemiseksi
DE69840432D1 (de) Arzneimittel zur behandlung der augen
AU8883998A (en) Pharmaceutical compositions for the treatment of ocular inflammations comprisingdexamethasone palmitate
FI961494L (fi) Farmaseuttisia koostumuksia ja niiden käyttö, etenkin hermoston rappeutumissairauksien hoitamiseksi
ATE205841T1 (de) Derivate von 5-naphthalin-1-yl-1,3-dioxanen, ihre herstellung und therapeutische anwendung
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
AU3737500A (en) Method of preventing the death of retinal neurons and treating ocular diseases